{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:06:35Z","timestamp":1786619195668,"version":"build-2736575974"},"reference-count":42,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2016,4,28]]},"published-print":{"date-parts":[[2016,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To identify consumer information needs about paracetamol, the most commonly used analgesic and antipyretic worldwide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective analysis of medicines questions from the public.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Australian consumer medicines call centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>\n                      Callers to National Prescribing Service\n                      <jats:italic>Medicines Line<\/jats:italic>\n                      between September 2002 and June 2010 (n=123\u2005217).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Enquiry profile: demographics, enquiry type and concurrent medicines included in paracetamol calls; question themes derived from subset of call narratives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Paracetamol comprised part of the enquiry in 5.2% of calls (n=6367). The caller age distribution for paracetamol calls was skewed towards a younger cohort, with 45.2% made by those aged 25\u201344 vs 37.5% in \u2018rest of calls\u2019. Significantly more paracetamol-related calls were made for a child (23.7%) compared with \u2018rest of calls\u2019 (12.7%, p&lt;0.001). The most frequent concurrently asked about medicines were codeine (11%, n=1521) and ibuprofen (6.4%, n=884). Questions underpinned by paracetamol risk (interaction, use in pregnancy\/lactation or other safety concerns) predominated (55.8%). When individual paracetamol enquiry types were compared with \u2018rest of calls\u2019, efficacy was most frequent (24.9% vs 22.8%); however, interaction (21.5% vs 14.8%), administration (15.5% vs 11%) and pregnancy\/lactation (13.8% vs 8.3%) categories were more prevalent for paracetamol calls (all p&lt;0.001). Enquiry type frequency also varied by patient age group, with questions about administration more common in younger groups and efficacy dominating in those over 45. Narrative analysis of over-represented paracetamol enquiry types showed specific concerns relevant to life stages: young children, those of reproductive age and the elderly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Consumers have many concerns about the use of paracetamol that may be under-recognised by healthcare providers, with the nature of enquiries differing across life stages. These concerns are not adequately addressed by available consumer information. Improving access to targeted information about paracetamol would promote the safe and effective use of this common medicine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2015-010860","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T00:06:10Z","timestamp":1465430770000},"page":"e010860","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["Consumer concerns about paracetamol: a retrospective analysis of a medicines call centre"],"prefix":"10.1136","volume":"6","author":[{"given":"Stephanie M","family":"Lau","sequence":"first","affiliation":[{"name":"Toowoomba Hospital, Toowoomba, Queensland, Australia"},{"name":"School of Medicine, The University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Treasure M","family":"McGuire","sequence":"additional","affiliation":[{"name":"School of Pharmacy, The University of Queensland, Woolloongabba, Brisbane, Australia"},{"name":"Mater Pharmacy Services, Mater Health Services, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke L","family":"van Driel","sequence":"additional","affiliation":[{"name":"Discipline of General Practice, School of Medicine, The University of Queensland, Royal Brisbane Women's Hospital, Herston, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,6,8]]},"reference":[{"key":"2025121400160660000_6.6.e010860.1","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/jgh.12196","article-title":"Paracetamol overdose in Victoria remains a significant health-care burden","volume":"28","author":"Sood","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"2025121400160660000_6.6.e010860.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h3705"},{"key":"2025121400160660000_6.6.e010860.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2004.05.005"},{"key":"2025121400160660000_6.6.e010860.4","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-013-1007-6"},{"key":"2025121400160660000_6.6.e010860.5","unstructured":"Office for National Statistics. Deaths related to drug poisoning in England and Wales, 2014 registrations. Newport: Office for National Statistics, 2015 (cited 31 October 2015). http:\/\/www.ons.gov.uk\/ons\/dcp171778_414574.pdf"},{"key":"2025121400160660000_6.6.e010860.6","unstructured":"Australian Institute of Health and Welfare. Drugs in Australia 2010: tobacco, alcohol and other drugs. Canberra: Australian Institute of Health and Welfare, 2011 (cited 15 September 2015). http:\/\/www.aihw.gov.au\/WorkArea\/DownloadAsset.aspx?id=10737420455"},{"key":"2025121400160660000_6.6.e010860.7","unstructured":"Australian Bureau of Statistics. Deaths collection: drug related deaths by type of drug (total drug related deaths). Canberra: Commonwealth of Australia, 2007 (cited 31 October 2015). http:\/\/www.drugfree.org.au\/fileadmin\/Media\/Reference\/DFA_DrugRelatedStats.pdf"},{"key":"2025121400160660000_6.6.e010860.8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.sapharm.2012.01.003","article-title":"Information sources used by parents to learn about medications they are giving their children","volume":"8","author":"Holappa","year":"2012","journal-title":"Res Social Adm Pharm"},{"key":"2025121400160660000_6.6.e010860.9","doi-asserted-by":"crossref","unstructured":"H\u00e4meen-Anttila K , Nordeng H , Kokki E , et al . Multiple information sources and consequences of conflicting information about medicine use during pregnancy: a multinational internet-based survey. J Med Internet Res 2014;16:e60. doi:10.2196\/jmir.2939","DOI":"10.2196\/jmir.2939"},{"key":"2025121400160660000_6.6.e010860.10","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17417"},{"key":"2025121400160660000_6.6.e010860.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2008.01322.x"},{"issue":"2","key":"2025121400160660000_6.6.e010860.12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/1158414-S0-000000000-00000","article-title":"Oxycodone\/paracetamol: a low-dose synergic combination useful in different types of pain","volume":"30","author":"Gatti","year":"2010","journal-title":"Clin Drug Investig"},{"key":"2025121400160660000_6.6.e010860.13","unstructured":"National Prescribing Service Limited. Medicines Line. Sydney: National Prescribing Service, 2012 (cited 28 July 2015). http:\/\/www.nps.org.au\/contact-us\/medicines-line"},{"key":"2025121400160660000_6.6.e010860.14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.sapharm.2007.05.001","article-title":"Utilization of a community pharmacy-operated national drug information call center in Finland","volume":"4","author":"Pohjanoksa-M\u00e4ntyl\u00e4","year":"2008","journal-title":"Res Soc Adm Pharm"},{"key":"2025121400160660000_6.6.e010860.15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.2042-7174.2010.00081.x","article-title":"Phone calls to a hospital medicines information helpline: analysis of queries from members of the public and assessment of potential for harm from their medicines","volume":"19","author":"Marvin","year":"2011","journal-title":"Int J Pharm Pract"},{"key":"2025121400160660000_6.6.e010860.16","unstructured":"Government of Ontario. Telehealth Ontario. Ontario: Government of Ontario, 2015 (cited 28 July 2015). https:\/\/www.ontario.ca\/page\/get-medical-advice-telehealth-ontario"},{"key":"2025121400160660000_6.6.e010860.17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001885"},{"key":"2025121400160660000_6.6.e010860.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"2025121400160660000_6.6.e010860.19","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2015. Oslo: Norwegian Institute of Public Health, 2014 (cited 31 October 2015). http:\/\/www.whocc.no\/filearchive\/publications\/2015_guidelines.pdf"},{"key":"2025121400160660000_6.6.e010860.20","unstructured":"Australian Bureau of Statistics. Families in regional, rural and remote Australia 2006 Census Data. Canberra: Australian Government, 2010 (cited 3 November 2015). http:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/Lookup\/1379.0.55.001Explanatory%20Notes12002-2006?OpenDocument ."},{"key":"2025121400160660000_6.6.e010860.21","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-012-2096-3"},{"key":"2025121400160660000_6.6.e010860.22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/15360288.2014.908993","article-title":"Patient perception and knowledge of acetaminophen in a large family medicine service","volume":"28","author":"Herndon","year":"2014","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"2025121400160660000_6.6.e010860.23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1017\/S1481803500007892","article-title":"Parental and health care provider understanding of childhood fever: a Canadian perspective","volume":"4","author":"Karwowska","year":"2002","journal-title":"CJEM"},{"key":"2025121400160660000_6.6.e010860.24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1177\/009286159903300332","article-title":"A model for understanding patient attribution of adverse drug reaction symptoms","volume":"33","author":"DeWitt","year":"1999","journal-title":"Drug Inf J"},{"key":"2025121400160660000_6.6.e010860.25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1365-2125.2009.03421.x","article-title":"Medication errors: the role of the patient","volume":"67","author":"Britten","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"2025121400160660000_6.6.e010860.26","doi-asserted-by":"publisher","DOI":"10.1348\/135910708X375344"},{"key":"2025121400160660000_6.6.e010860.27","doi-asserted-by":"publisher","DOI":"10.1080\/08870449708406723"},{"key":"2025121400160660000_6.6.e010860.28","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.6016"},{"key":"2025121400160660000_6.6.e010860.29","unstructured":"National Health Service Choices. Medicines Information. London: National Health Service, 2014 (cited 31 October 2015). http:\/\/www.nhs.uk\/conditions\/Medicinesinfo\/Pages\/Introduction.aspx"},{"key":"2025121400160660000_6.6.e010860.30","unstructured":"Medical and Healthcare Products Regulatory Agency. Best practice guidance on the labelling and packaging of medicines. London: Government of the United Kingdom, 2014 (cited 31 October 2015) https:\/\/www.gov.uk\/government\/publications\/best-practice-in-the-labelling-and-packaging-of-medicines ."},{"key":"2025121400160660000_6.6.e010860.31","unstructured":"Electronic Medicines Compendium. About the eMC. Leatherhead, UK: Datapharm, 2015(cited 31 October 2015). http:\/\/www.medicines.org.uk\/emc\/about-the-emc"},{"key":"2025121400160660000_6.6.e010860.32","unstructured":"Sanofi. Panamax: Consumer Medicines Information. Sydney: Sanofi, 2014 (cited 8 September 2015). http:\/\/www.sanofi.com.au\/products\/aus_cmi_panamax.pdf"},{"key":"2025121400160660000_6.6.e010860.33","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.22.2618"},{"key":"2025121400160660000_6.6.e010860.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(00)00341-5"},{"key":"2025121400160660000_6.6.e010860.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-7625.2004.00281.x"},{"key":"2025121400160660000_6.6.e010860.36","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-009-9293-0"},{"key":"2025121400160660000_6.6.e010860.37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1472-6963-14-183","article-title":"Enhancing provision of written medicine information in Australia: pharmacist, general practitioner and consumer perceptions of the barriers and facilitators","volume":"14","author":"Hamrosi","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"2025121400160660000_6.6.e010860.38","first-page":"11","article-title":"Paracetamol: mechanism of action, applications and safety concern","volume":"71","author":"J\u00f3\u017awiak-Bebenista","year":"2014","journal-title":"Acta Pol Pharm"},{"key":"2025121400160660000_6.6.e010860.39","unstructured":"Collins N . Paracetamol \u2018should be prescription-only\u2019. London: The Telegraph, 2012 (cited 14 July 2014). http:\/\/www.telegraph.co.uk\/news\/uknews\/9134065\/Paracetamol-should-be-prescription-only.html"},{"key":"2025121400160660000_6.6.e010860.40","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aep338"},{"key":"2025121400160660000_6.6.e010860.41","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-200111000-00008"},{"key":"2025121400160660000_6.6.e010860.42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pec.2014.11.025","article-title":"\u201cBut it's just paracetamol\u201d: Caregivers\u2019 ability to administer over-the-counter painkillers to children with the information provided","volume":"98","author":"Bennin","year":"2015","journal-title":"Patient Educ Couns"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2015-010860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:16:16Z","timestamp":1765700176000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2015-010860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,8]]},"published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1136\/bmjopen-2015-010860"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2015-010860","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}